Understanding Your SPF Data (FDA Method) Webinar

 

Sunscreens are regulated by the FDA as Over the Counter (OTC) drugs. Before they enter the market, they must be shown to be both safe and effective and must comply with requirements listed in the FDA’s OTC sunscreen monograph. This webinar has been assembled as an educational session to help sunscreen suppliers, formulators, marketers, and manufacturers understand the pertinent details behind the SPF product testing.

Topics include, an overview of the FDA method, determination and validation of SPF values, product performance as it pertains to the FDA monograph, understanding the results of your SPF testing and how to interpret these results for industry compliance and label claims. After attending this webinar, participants will be in a better position to make strategic well-informed decisions based on the data they will receive from this type of testing and analysis that best fits their needs and product development goals.

Tuesday, April 18th 2023 10am-11am EDT Register

Tuesday, April 18th 2023 2pm-3pm EDT Register

Tuesday, May 23rd 2023 10am-11am EDT Register 

Tuesday, May 23rd 2023 2pm-3pm EDT Register 

Speakers

Chelcie Mejia
Chelcie Mejia is currently the Photobiology Manager at Eurofins CRL Cosmetics, Inc. North Carolina, USA where she is the Principal Investigator of the In-Vivo and In-Vitro SPF studies and oversees the daily clinical testing operations of R&D sun protecting products.  She has 5+ years of experience in the SPF industry.

Dominique Sawyer
Dominique Sawyer is currently the Photobiology Team Lead at Eurofins CRL Cosmetics, Inc. North Carolina, USA where he is responsible for initiating the studies, including IRB submissions and product check in. Dominique also handles the training procedures for our new staff members and test product assignment. He has been with the company for almost a year.

For all of our Sunscreen Testing Services, please Click Here.

For additional Testing Services, please Click Here.

Related Posts

Sorry, the comment form is closed at this time.